Red blood cell profile in patients with mild, moderate and severe COVID-19

Authors

  • Khushbhun Nahar Layla Department of Physiology, Ibrahim Medical College, Dhaka
  • Shahanara Yeasmin Department of Physiology, Dhaka Medical College, Dhaka
  • Afrina Binte Azad Department of Physiotherapy, National Institute of Traumatology and Orthopaedic Rehabilitation, Dhaka
  • Masba Uddin Chowdhury Department of Haematology, Evercare Hospital Dhaka
  • Nasrin Sultana Department of Biochemistry, Shaheed Tajuddin Ahmed Medical College, Gazipur
  • Abul Fazal Shah Muhammad Shazedur Rahman Department of Physiology. Tangail Shekh Hasina Medical College, Tangail
  • Mohammad Mostafizur Rahman Institute of Epidemiology, Disease control and Research, Mohakhali, Dhaka
  • Rukaia Labiba Rafa Department of Biochemistry, Dhaka Medical College, Dhaka

Keywords:

COVID-19, Red blood cell, Coronavirus disease 2019

Abstract

Background and objectives: Coronavirus disease 2019 (COVID-19) pandemic has affected millions of people world-wide. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Increasing evidence has shown abnormalities of different hematological parameters with the severity of the diseases. The present study was undertaken to determine the red blood cell (RBC) profile in different categories of COVID-19 patients.

Materials and methods: The study was conducted from January 2020 to December 2020. Reverse transcriptase-polymerase chain reaction (RT-PCR) positive COVID-19 patients were enrolled. Patients were categorized into mild, moderate and severe COVID-19 cases. Blood samples were analyzed by Automated Hematology Analyzer for hemoglobin concentration, total erythrocyte count and RBC indices. ANOVA followed by Bonferroni test, Chi square test, Spearman’s rho correlation coefficient test were performed as applicable using SPSS version 25.0.

Results: A total of 100 RT-PCR positive COVID-19 patients were included in the study. There were 25, 38 and 37 mild, moderate and severe cases respectively. The mean age of the study participants was 44.68 + 13.16 years (range: 18 to 65 years). There were 67 (67%) males and 33 (33%) females. No significant difference in hemoglobin (Hb), hematocrit (HCT), total RBC count, red blood cell distribution width (CDW) was observed among the three groups. Significant negative correlation of mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH); rs-0.362 & -0.255 respectively) was observed with disease severity.

Conclusion: The study showed low MCV and MCH were significantly related with the severity of the COVID-19 illness. Therefore, comprehensive analysis of the RBC profile would be helpful to understand the disease course.

Ibrahim Med. Coll. J. 2021; 15(2): 26-31

Downloads

Download data is not yet available.
Abstract
363
PDF
1423

Downloads

Published

2021-08-25

How to Cite

Layla, K. N. ., Yeasmin, S., Azad, A. B., Chowdhury, M. U. ., Sultana, N. ., Muhammad Shazedur Rahman, A. F. S. ., Rahman, M. M. ., & Rafa, R. L. (2021). Red blood cell profile in patients with mild, moderate and severe COVID-19. IMC Journal of Medical Science, 15(2), 26–31. Retrieved from https://www.banglajol.info/index.php/IMCJMS/article/view/55811

Issue

Vol. 15 No. 2 (2021)

Section

Original Articles

License

Copyright (c) 2021 Khushbhun Nahar Layla, Shahanara Yeasmin, Afrina Binte Azad, Masba Uddin Chowdhury, Nasrin Sultana, Abul Fazal Shah Muhammad Shazedur Rahman, Mohammad Mostafizur Rahman, Rukaia Labiba Rafa

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in IMCJMS agree to the following terms that:

  1. Authors retain copyright and grant IMCJMS the right of first publication of the work.

  2. Creative Commons Licence
    Articles in IMCJMS are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.